CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

ONCY: Seeking Registration Pathway for Part B of REO 033 Trial

RegulatoryREO 033Neutral
AI Analysis

Summary

Oncolytics Biotech is seeking a registration pathway for Part B of the REO 033 trial with regulatory authorities.

Clinical Trial Data

Importance:3/10
Sentiment:
0.00
clinical_trialregulatoryREO_033
Related Companies

Read the original article

Published by yahoo_finance on July 16, 2026 11:16 AM

Read Original